Isikhathi esivamile sokujiya komzimba womuntu siyahlukahluka kuye ngendlela yokuthola.
Okulandelayo izindlela eziningana ezivamile zokuthola kanye nezindawo zazo zokubhekisela ezijwayelekile ezihambisanayo:
1 Isikhathi se-thromboplastin esingaphelele esisebenzayo (i-APTT):
Ibanga elijwayelekile lokubhekisela ngokuvamile liyimizuzwana engu-25-37. I-APTT ibonisa kakhulu umsebenzi wezinto ezijiyile VIII, IX, XI, XII, njll. endleleni yokujiyile yangaphakathi.
2 Isikhathi se-Prothrombin (PT):
Inani elijwayelekile lokubhekisela livame ukuba yimizuzwana eyi-11-13. I-PT isetshenziswa kakhulu ukuhlola umsebenzi wezinto ezijiyayo II, V, VII, X, njll. endleleni yokujiya kwangaphandle.
3 Isilinganiso esijwayelekile samazwe ngamazwe (INR):
Ububanzi obujwayelekile bokubhekisela buphakathi kuka-0.8 no-1.2. INR ibalwa ngokusekelwe enanini le-PT futhi isetshenziselwa ukuqapha umphumela wokwelapha wemithi yomlomo yokuvimbela ukugabha kwegazi (njenge-warfarin) ukuze imiphumela yokuhlolwa phakathi kwamalebhu ahlukene ifane.
4 I-Fibrinogen (i-FIB):
Ibanga elijwayelekile lokubhekisela lingu-2-4g/L. I-FIB iyi-plasma glycoprotein eyenziwe yisibindi futhi idlala indima ebalulekile enqubweni yokujiya. Iguqulwa ibe yi-fibrin ngaphansi kwesenzo se-thrombin ukuze yakhe ihlule legazi.
Kufanele kuqashelwe ukuthi imishini yokuhlola kanye nama-reagents emalabhorethri ahlukene angahluka, futhi amanani ajwayelekile okubhekisela angahluka kancane. Ngaphezu kwalokho, ezinye izici zomzimba (njengobudala, ubulili, ukukhulelwa, njll.) kanye nezici ze-pathological (njengesifo sesibindi, izifo zesistimu yegazi, ukuthatha imithi ethile, njll.) nazo zizothinta isikhathi sokujiya. Ngakho-ke, lapho kuhunyushwa imiphumela yesikhathi sokujiya, ukuhlaziywa okuphelele kudingeka kwenziwe kuhlanganiswe nesimo esithile sesiguli.
I-BEIJING SUCCEEDER TECHNOLOGY INC.
UKUHLOLWA KWESIKHUNGO SOKUXHUMANA KWESIKHUNGO
ISICELO SOKUHLAZIYA IZINTO EZINGAKUSETSHENZISWA
I-Beijing Succeeder Technology Inc. (ikhodi yesitoko: 688338) ibilokhu ihileleke kakhulu emkhakheni wokuxilongwa kokuqina kwegazi selokhu yasungulwa ngo-2003, futhi izibophezele ekubeni ngumholi kulo mkhakha. Indlunkulu yayo eBeijing, inethimba eliqinile le-R&D, lokukhiqiza kanye nelokuthengisa, eligxile ekusungulweni nasekusetshenzisweni kobuchwepheshe bokuxilonga i-thrombosis kanye ne-hemostasis.
Ngenxa yamandla ayo obuchwepheshe avelele, iSucceeder iwine ama-patents agunyaziwe angu-45, okuhlanganisa ama-patents okusungula angu-14, ama-patents emodeli yokusetshenziswa angu-16 kanye nama-patents okuklama angu-15. Le nkampani futhi inezitifiketi zokubhaliswa komkhiqizo wedivayisi yezokwelapha zesigaba sesi-2 ezingu-32, izitifiketi zokufaka zesigaba sesi-3, kanye nesitifiketi se-EU CE semikhiqizo engu-14, futhi iphumelele isitifiketi sesistimu yokuphatha ikhwalithi ye-ISO 13485 ukuqinisekisa ubuhle nokuzinza kwekhwalithi yomkhiqizo.
I-Succeeder ayiyona nje ibhizinisi elibalulekile le-Beijing Biomedicine Industry Leapfrog Development Project (G20), kodwa futhi yafika ngempumelelo kwi-Science and Technology Innovation Board ngo-2020, yafinyelela intuthuko eqhubekayo yenkampani. Njengamanje, inkampani yakhe inethiwekhi yokuthengisa kazwelonke ehlanganisa amakhulu ama-ejenti namahhovisi. Imikhiqizo yayo ithengiswa kahle ezingxenyeni eziningi zezwe. Iphinde yandise ngenkuthalo izimakethe zaphesheya kwezilwandle futhi ithuthukisa njalo ukuncintisana kwayo kwamazwe ngamazwe.
Ikhadi lebhizinisi
I-WeChat yesiShayina